Teenager who researched medical cannabis to study at Oxford
Ariana Howells, 17, achieved three A*s and one A in A-level biology, chemistry, maths, and English literature, plus 97% in her Extended Project Qualification, and will now take her place at Oxford University's St Hilda College to study biochemistry.
Ariana, from Barry in Wales, carried out research examining the extent THC, a component of cannabis, can 'negatively affect sleep architecture' as part of her studies.
The project highlighted the drug's promise, as well as gaps in existing research.
'There were only seven studies worth citing,' Ariana, a scholarship student at Cardiff Sixth Form College, said.
'I expected clearer answers, but what I found was a real need for more in-depth, unbiased research. This is something I want to keep exploring at university and beyond.'
Ariana's interest in medical cannabis is personal as well as academic.
Her mother lives with Crohn's disease, a chronic inflammatory bowel condition with no cure, and medical cannabis has played a crucial role in improving her quality of life.
Her parents run a medical cannabis clinic in Wales – Cannabis Clinic Cardiff – where the teenager has spent the last two years helping with admin and learning about the evolving science behind the plant-based treatment.
She said: 'Seeing my mum's condition and the way cannabis helped her and the patients who visit our clinic really opened my eyes to its medical potential.
'My dad is also a senior psychiatrist, so I've grown up in a household where science and care come together.'
Outside of school, Ariana earned gold in the Biology Olympiad, reached the semi-finals in the International Biology Bowl, and is also a competitive ice skater, having competed in the juvenile British championships in 2020 for synchronised ice skating.
Now preparing for Oxford, Ariana plans to channel her energy into drug development and mental health research – with a special interest in how medical cannabis could one day transform care.
'There's still stigma and strong media opinions,' she said.
'But science is about asking difficult questions and being open to where the evidence leads.'
Welsh Education Secretary Lynne Neagle extended her congratulations to students picking up their results on Thursday.
She said: 'Every learner opening their results today has earned the right to feel immense pride in what they've accomplished, and these achievements demonstrate remarkable determination.
'As you look towards your future, whether that involves starting an apprenticeship, entering employment, or beginning studies at university, I wish you 'pob lwc'.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
7 hours ago
- Daily Mirror
DWP warning for pensioners as payments could stop
The DWP has strict rules on Attendance Allowance State pensioners with certain conditions could see their benefits payments halted, the DWP has warned. The DWP has strict Attendance Allowance rules that older people need to be aware of, or they risk having their payments stopped. The DWP has stressed that any changes in lifestyle or circumstances must be reported. It warns: "You could be taken to court or have to pay a penalty if you give wrong information or do not report a change in your circumstances." Changes that need to be reported include alterations in the level of help needed, changes in condition, hospitalisation or moving into a care home. Other significant changes could be if a medical professional has given a prognosis of 12 months or less to live, or plans to leave the country for more than 4 weeks. Additional changes that require reporting include imprisonment, changes in name, address or bank details, a desire to stop receiving benefits, or changes in doctor's details. If there are changes in immigration status for those who aren't British citizens, these also need to be reported. The lower rate of Attendance Allowance is £73.90 a week (£3,842 a year), which is received if help or supervision is needed during either the day or the night, reports Birmingham Live. The higher rate is £110.40 a week (£5,740 a year). This is granted if help or supervision is needed during both the day and the night, or if a medical professional has given a prognosis of 12 months or less to live. Attendance Allowance supports conditions such as: Arthritis. Spondylosis. Back Pain – other / precise diagnosis not specified. Disease of the muscles, bones or joints. Trauma to limbs. Blindness. Deafness. Heart disease. Chest disease. Asthma. Cystic fibrosis. Cerebrovascular disease. Peripheral vascular disease. Epilepsy. Neurological diseases. Multiple sclerosis. Parkinson's. Motor neurone disease. Chronic pain syndromes. Diabetes mellitus. Metabolic disease. Traumatic paraplegia/tetraplegia. Major trauma other than traumatic paraplegia/tetraplegia. Learning difficulties. Psychosis. Psychoneurosis. Personality disorder. Dementia. Behavioural disorder. Alcohol and drug abuse. Hyperkinetic syndrome. Renal disorders. Inflammatory dowel disease. Bowel and stomach disease. Blood disorders. Haemophilia. Multi system disorders. Multiple allergy syndrome. Skin disease. Malignant disease. Severely mentally impaired. Double amputee. Deaf/Blind. Haemodialysis. Frailty. Total parenteral nutrition. AIDS.
Daily Mirror
8 hours ago
- Daily Mirror
Warning issued as common toxic substance could 'kill dog in minutes'
Dog owners are being urged to keep their dogs away from a common toxic substance that is found in freshwater and which can make them extremely ill and even lead to death Be careful the next time you bring your dog out for a walk – a vet has warned that this common algae could kill them. Most dogs will get thirsty after walking through the park or playing a ball game – especially in the recent hot weather. This means they may end up taking a quick drink from a puddle, river or pond. But, a vet warns that this seemingly innocent act could be deadly. Dr Maryam Achoukhi, Veterinary Surgeon in partnership with the Pettifor Trust urges all dog owners to be vigilant about blue-green algae, as it can be found in British freshwaters. The algae, which are technically a type of bacteria called cyanobacteria, thrive in warm, calm and nutrient-rich environments like lakes, ponds and rivers. Part of what makes them particularly dangerous is that it's impossible to tell if a bloom is toxic just by looking at it. Dr Maryam Achoukhi explains: 'While the majority of species are harmless, a subset produces potent toxins that can cause rapid-onset neurotoxic or hepatotoxic effects.' She cautions that if your dog ingests or even makes contact with this water, it can make them extremely ill. Symptoms can appear within minutes to hours and include vomiting and diarrhoea, excessive drooling, muscle tremors and seizures and liver failure. In more severe cases, it can lead to death. Dr Achoukhi advises owners to keep their dogs away from water that appears scummy, discoloured, foamy or stagnant to protect them. To avoid this potentially devastating algae, your best bet is to bring a water bottle for your dog on a walk – which could be the difference between life and death. It's not the only issue that dog owners need to be on the look out for, either. A veterinary expert has recently cautioned owners over the prevalence of diarrhoea in their pets. According to a study conducted by the Royal Veterinary College (RVC) in the UK, one in every 12 dogs in the UK is diagnosed with diarrhoea-related issues each year, while certain breeds are more likely to experience episodes of 'the runs' than others. Sean McCormack, head vet at advised that while while diarrhoea is not normally considered an emergency in dogs (particularly if they are otherwise healthy), if the condition lasts beyond 24 to 48 hours, or if it appears intermittently over time, it's a good idea to contact your vet for guidance. Potential causes of diarrhoea in dogs vary, and include genetic predispositions, stress, ingesting foreign objects and even switching to a different brand of dog food.
Spectator
a day ago
- Spectator
Mounjaro won't be the last drug company to bow to Trump
If you need to lose a few pounds after enjoying the French or Italian food a little too much on your summer holiday, there might soon be a problem. The cost of one of the new weight loss drugs that has become so popular in recent months is about to get a lot more expensive. The American drugs giant Eli Lilly doubling the price of Mounjaro in the UK. The price of one diet pill does not make a great deal of difference. The trouble is, the decision was prompted by President Trump's determination to make the cost of medicines a lot fairer between the United States and the rest of the world. This is going to end up costing Britain, along with many other countries, a lot of money. Eli Lilly will be increasing the British price of Mounjaro, the most popular and effective weight loss injection, from £92 for a medium-sized dose to £180, and from £122 to £330 for a stronger version. The reason is simple. President Trump, with his typically blunt language, complained about how a friend of his brought 'the fat drug' in London at a far lower price than in the US despite being 'the same box made in the same plant by the same company'. More broadly, President Trump has made a big issue of the huge differences in drug prices between the US and other countries. He has imposed tariffs that could go as high as 250 per cent to force the major pharmaceutical companies to bring their manufacturing onshore and lower prices for American patients. Eli Lilly's response, quite rationally, has been to increase the price in the UK to start to close the gap and keep the President happy. Eli Lilly won't be the last pharmaceutical company to do this. Truth be told, President Trump has a point about the unfairness of drug prices in his country. On average, medicines cost 2.7 times more in the US than they do in the rest of the world. That might make sense for poor countries, but it is hard to see why developed economies in Europe, the Gulf or Asia should pay so much less for medicines than America does. In effect, the US subsidises the rest of the world, paying for the huge cost of research while the rest of the world gets drugs at far less than they would otherwise cost. But if that is rebalanced, medicines will inevitably get a lot more expensive, both for private patients and in time for the NHS as well. Given that the UK spends £34 billion a year on pharmaceuticals and that £19 billion of that comes from the NHS, that is going to be a very big bill – and one that we can barely afford.
